BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Holistic medicine
,
Doxycycline
,
rs2476601
,
VEGFA
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
UDP-N-acetylglucosamine metabolic process
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Salivary gland
Duodenum
Bone marrow
Liver
Globus pallidus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tularemia
Wound of skin
Alpha-1-antitrypsin deficiency
Bacterial septicemia
Bacterial infection of skin
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Glesatinib
NU 7026
A 443654
QL-X- 92
testosterone 17 beta-cypionate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
INSM2
PCDH11X
ARHGEF5
NR5A1
PCDH11X
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7.101 cells with CRISPR targeted gene knockouts
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
The Cancer Genome Atlas (TCGA) - gene expression in glioblastoma multiforme
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for UDP-N-acetylglucosamine metabolic process
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ